Anti-VEGF and anti-EGFR agents open up new horizons changing the landscape for their associations.
, Nice, France. gerard.milano@nice.unicancer.fr.
Gerard
G
Milano
D000068258:Bevacizumab; D066246:ErbB Receptors; D006801:Humans; D042461:Vascular Endothelial Growth Factor A
D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D066246:ErbB Receptors